Back to Solutions
Market Access

Market Access Implementation

Pricing strategy, HEOR, payer engagement, and formulary execution for pharmaceutical market access.

50+
Markets Covered
90%
Formulary Success Rate
20%
Price Optimization
8w
Dossier Prep Time

Consulting Overview

Our Market Access Implementation service helps pharmaceutical companies navigate the complex payer landscape and secure optimal pricing, reimbursement, and formulary placement. We combine deep market access expertise with real-world evidence and HEOR capabilities.

From pricing strategy to payer negotiation, we help you build a market access function that delivers results across global markets.

Strategic Service Areas

Pricing & Reimbursement Strategy

Value-based pricing, reimbursement pathway design, and global pricing strategy.

  • • Value-based pricing
  • • Reimbursement pathway design
  • • Global pricing strategy
  • • Launch pricing optimization

HEOR & Evidence Generation

Economic models, RWE studies, and evidence packages for payer dossiers.

  • • Economic model development
  • • RWE study design
  • • Payer dossier preparation
  • • Budget impact models

Payer Engagement & Negotiation

Payer mapping, value communication, and negotiation support.

  • • Payer landscape mapping
  • • Value communication
  • • Negotiation support
  • • Managed entry agreements

Formulary & Reimbursement Execution

Formulary submissions, PBM negotiations, and reimbursement monitoring.

  • • Formulary submission strategy
  • • PBM negotiations
  • • Reimbursement monitoring
  • • Access tracking

Our Methodology

01

Landscape Analysis

Analyze payer landscape, reimbursement environment, and access barriers.

02

Strategy Development

Develop pricing, evidence, and engagement strategy tailored to each market.

03

Evidence Generation

Build economic models, RWE studies, and payer dossiers.

04

Execution & Monitoring

Support payer engagement, negotiations, and ongoing access monitoring.

Key Capabilities

Value-Based
Pricing Strategy
Evidence-Driven
HEOR & RWE
Strategic
Payer Engagement
Proven
Formulary Execution

Frequently Asked Questions

What is HEOR and why is it important?

Health Economics and Outcomes Research (HEOR) generates the evidence needed to demonstrate value to payers. It includes economic models, real-world evidence studies, and payer dossiers that support pricing and reimbursement negotiations.

How do you support payer negotiations?

We provide payer landscape mapping, value communication materials, negotiation strategy support, and managed entry agreement design to help you secure optimal access and pricing.

Which markets do you cover?

We cover all major markets including US, EU5 (UK, DE, FR, IT, ES), Japan, Canada, and emerging markets, with localized strategies for each reimbursement system.

What is value-based pricing?

Value-based pricing sets drug prices based on the clinical and economic value they deliver to patients and healthcare systems, supported by HEOR evidence and aligned with payer expectations.

Consulting Features

  • Value-based pricing
  • HEOR & economic models
  • Payer dossier preparation
  • RWE strategy
  • Payer negotiation support
  • Global access strategy

Markets Supported

United States
EU5 (UK, DE, FR, IT, ES)
Japan
Canada
Emerging Markets

Optimize Your Market Access?

Get expert market access consulting with AI-powered insights.

Schedule Consultation